ONDRI_study

An important announcement from ONDRI: As of May 1, 2023, ONDRI has ceased all research and knowledge translation activities.

We are so grateful for the community we have built over the past decade and remain committed to improving the quality of life for those living with neurodegenerative diseases, stroke and dementia.

For ONDRI resources, please visit www.ondri.ca

For updates from OBI, follow The Ontario Brain Institute

will have an increasingly important role to play in predicting health issues in primary care and guiding capacity planning across .

Our new study examines signs and symptoms of in EMRs for predictive ability.

More: https://bit.ly/3D9rn48

According to a report from Alzheimer Society of Canada, there are at least 28,000 people in Canada living with . There are likely many more.

Diagnosis of this disorder at an earlier stage of life than is typical presents many complexities.

More here: https://bit.ly/3kgHBSq

Good fats go bad in diseased small vessels in the 🧠

A new ONDRI publication, led by researchers at Sunnybrook Research Institute, proposes an innovative disease pathway for small vessel disease and uncovers a new .

Read more about it in our latest blog post: https://bit.ly/3vGOQWf

📚 New publication alert! ONDRI researchers Ashley C Parr, Doug Munoz et al, supported by Parkinson Canada grant, used a simplified digital form of ‘rock paper scissors’ to measure the impact of function on decision making in people with

More through link in bio.

Decentralized clinical trials (sometimes called remote or virtual clinical trials) are clinical trials done with participants located outside of the study site.

Clinical Trials Ontario is inviting you to participate in a survey about being a participant in decentralized clinical trials.

Learn more about the survey here: https://tinyurl.com/469ehe8s

Today we bring you part 2 of “Adjusting Expectations from the ” through the lens of a family living with . 🎄

They hope that by candidly sharing their own experiences, they are providing support and perspective to others: https://bit.ly/3G3oq6X

New potentially disease modifying drugs are in the pipe for and contributing diseases. These will require a deeper, more ‘personalized medicine’ approach to choosing the best candidates. HANDDS-ONT is working towards uncovering relevant , to help enable this.

Know someone who may be interested in participating? www.ondri.ca/handds

❄ The is a joyous time of celebration and tradition. Yet, for families of people living with , new challenges can mean they need to dramatically adjust their expectations.

This year we bring you the of one such family: https://bit.ly/3FmZVQD

Multiple areas in the are involved in controlling movements. Measures such as pupil response times to different stimuli are easy to collect, and may help us diagnose diseases, in life 👁️

This short video explains a little more: https://www.youtube.com/watch?v=MHzCIw3t3Do

A recent study from Alzheimer Society of Canada estimates that 61.8% of people living with in Canada are , with this proportion expected to grow. Women also carry a heavy load when it comes to diseases.

Let’s take a moment to salute women!

can promote safe and effective mobility, support independence and help reduce the risk of .

But are they used as often as reported? Our innovative new study is looking into this issue.

Interested? https://bit.ly/3Vdp8DQ